Why the study?
Does the 2004 ISHLT revision improve concordance among pathologists for grading cardiac allograft rejection?
Population
Cardiac allograft recipients in the Second Cardiac Allograft Rejection Gene Expression Observational Study
Design
Cohort
Authors
Loading...
Reliance on EMB ≥2R alone warrants caution in rejection decisions; leaves open refined ISHLT criteria or adjunctive diagnostics.
Does the 2004 ISHLT revision improve concordance among pathologists for grading cardiac allograft rejection?
The 2004 ISHLT grading system for endomyocardial biopsies shows poor inter-pathologist agreement for higher grades, suggesting it should not be used in isolation for clinical decisions.
Crespo‐Leiro et al. (2012) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: